SEC Form 424B7 filed by Mind Medicine (MindMed) Inc.
(To Prospectus Dated June 28, 2024)
| | |
Page
|
| |||
| | | | S-ii | | | |
| | | | S-1 | | | |
| | | | S-7 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-11 | | | |
| | | | S-12 | | | |
| | | | S-14 | | | |
| | | | S-16 | | | |
| | | | S-16 | | | |
| | | | S-16 | | | |
| | | | S-17 | | |
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 18 | | | |
| | | | | 23 | | | |
| | | | | 24 | | | |
| | | | | 24 | | | |
| | | | | 24 | | | |
| | | | | 25 | | |
| | |
Common Shares
Beneficially Owned Prior to Offering |
| | | | | | | |
Common Shares
Beneficially Owned After Offering |
| ||||||||||||||||||
Selling Stockholder
|
| |
Number of
Common Shares |
| |
Percentage of
Outstanding Common Shares |
| |
Number of
Common Shares Registered for Sale Hereby |
| |
Number of
Common Shares |
| |
Percentage of
Outstanding Common Shares |
| |||||||||||||||
Deep Track Biotechnology Master Fund, LTD(1)
|
| | | | 7,065,099 | | | | | | 9.14% | | | | | | 4,000,000 | | | | | | 3,065,099 | | | | | | 3.96% | | |
Commodore Capital Master LP(2)
|
| | | | 7,693,859 | | | | | | 9.99% | | | | | | 4,000,000 | | | | | | 5,428,775 | | | | | | 6.89% | | |
Attention: Corporate Secretary
One World Trade Center, Suite 8500,
New York, New York 10007
Telephone: (212) 220-6633
Warrants
Debt Securities
Units
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 18 | | | |
| | | | | 23 | | | |
| | | | | 24 | | | |
| | | | | 24 | | | |
| | | | | 24 | | | |
| | | | | 25 | | |